1. Home
  2. ARQT vs GIC Comparison

ARQT vs GIC Comparison

Compare ARQT & GIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • GIC
  • Stock Information
  • Founded
  • ARQT 2016
  • GIC 1949
  • Country
  • ARQT United States
  • GIC United States
  • Employees
  • ARQT N/A
  • GIC N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • GIC Industrial Machinery/Components
  • Sector
  • ARQT Health Care
  • GIC Industrials
  • Exchange
  • ARQT Nasdaq
  • GIC Nasdaq
  • Market Cap
  • ARQT 1.7B
  • GIC 860.9M
  • IPO Year
  • ARQT 2020
  • GIC 1995
  • Fundamental
  • Price
  • ARQT $13.78
  • GIC $28.28
  • Analyst Decision
  • ARQT Strong Buy
  • GIC
  • Analyst Count
  • ARQT 6
  • GIC 0
  • Target Price
  • ARQT $18.80
  • GIC N/A
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • GIC 81.2K
  • Earning Date
  • ARQT 08-13-2025
  • GIC 07-29-2025
  • Dividend Yield
  • ARQT N/A
  • GIC 3.68%
  • EPS Growth
  • ARQT N/A
  • GIC N/A
  • EPS
  • ARQT N/A
  • GIC 1.59
  • Revenue
  • ARQT $212,819,000.00
  • GIC $1,313,500,000.00
  • Revenue This Year
  • ARQT $61.15
  • GIC $4.19
  • Revenue Next Year
  • ARQT $37.98
  • GIC $4.08
  • P/E Ratio
  • ARQT N/A
  • GIC $17.90
  • Revenue Growth
  • ARQT 100.03
  • GIC N/A
  • 52 Week Low
  • ARQT $7.86
  • GIC $20.79
  • 52 Week High
  • ARQT $17.75
  • GIC $36.17
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 46.51
  • GIC 65.67
  • Support Level
  • ARQT $13.51
  • GIC $26.79
  • Resistance Level
  • ARQT $14.31
  • GIC $28.41
  • Average True Range (ATR)
  • ARQT 0.61
  • GIC 0.60
  • MACD
  • ARQT -0.01
  • GIC 0.07
  • Stochastic Oscillator
  • ARQT 46.95
  • GIC 94.51

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

Share on Social Networks: